These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26949264)

  • 21. Overcoming therapeutic inertia in patients with hypertension.
    Nesbitt SD
    Postgrad Med; 2010 Jan; 122(1):118-24. PubMed ID: 20107295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of hypertension in patients with diabetes: the place of angiotensin-II receptor blockers.
    Kalaitzidis R; Bakris G
    Diabetes Obes Metab; 2009 Aug; 11(8):757-69. PubMed ID: 19519867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertension in the Kidney Transplant Recipient: Overview of Pathogenesis, Clinical Assessment, and Treatment.
    Glicklich D; Lamba R; Pawar R
    Cardiol Rev; 2017; 25(3):102-109. PubMed ID: 27548684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertensive crisis: an update on clinical approach and management.
    Ipek E; Oktay AA; Krim SR
    Curr Opin Cardiol; 2017 Jul; 32(4):397-406. PubMed ID: 28306673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The problem of uncontrolled hypertension.
    Lindholm LH
    J Hum Hypertens; 2002 Aug; 16 Suppl 3():S3-8. PubMed ID: 12140722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of hypertension in CKD.
    Horowitz B; Miskulin D; Zager P
    Adv Chronic Kidney Dis; 2015 Mar; 22(2):88-95. PubMed ID: 25704344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension in patients with diabetes. Why is aggressive treatment essential?
    Bakris G; Sowers J; Epstein M; Williams M
    Postgrad Med; 2000 Feb; 107(2):53-6, 61-4. PubMed ID: 10689408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How early should blood pressure control be achieved for optimal cardiovascular outcomes?
    Weir MR; Zappe D; Orloski LA; Sowers JR
    J Hum Hypertens; 2011 Apr; 25(4):211-7. PubMed ID: 20596060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-circulating leptin levels are associated with increased blood pressure in uncontrolled resistant hypertension.
    de Haro Moraes C; Figueiredo VN; de Faria AP; Barbaro NR; Sabbatini AR; Quinaglia T; Ferreira-Melo SE; Martins LC; Demacq C; Júnior HM
    J Hum Hypertens; 2013 Apr; 27(4):225-30. PubMed ID: 22810172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological management of hypertension in the elderly and frail populations.
    Correa A; Rochlani Y; Khan MH; Aronow WS
    Expert Rev Clin Pharmacol; 2018 Aug; 11(8):805-817. PubMed ID: 30004797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapy.
    Basile J; Neutel J
    Ther Adv Cardiovasc Dis; 2010 Apr; 4(2):119-27. PubMed ID: 20042448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure control over time in childhood-onset systemic lupus erythematous.
    Avar Aydin PO; Shan J; Brunner HI; Mitsnefes MM
    Lupus; 2018 Apr; 27(4):657-664. PubMed ID: 29301473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct renin inhibitors as antihypertensive agents.
    Israili ZH; Velasco M; Bermúdez V
    Am J Ther; 2010; 17(3):237-54. PubMed ID: 20479579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of blood pressure control rates and outcomes.
    Bakris G; Sarafidis P; Agarwal R; Ruilope L
    J Am Soc Hypertens; 2014 Feb; 8(2):127-41. PubMed ID: 24309125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practice.
    Corrao G; Nicotra F; Parodi A; Zambon A; Heiman F; Merlino L; Fortino I; Cesana G; Mancia G
    Hypertension; 2011 Oct; 58(4):566-72. PubMed ID: 21825231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension management in type 2 diabetes mellitus: recommendations of the Joint National Committee VII.
    Whaley-Connell A; Sowers JR
    Endocrinol Metab Clin North Am; 2005 Mar; 34(1):63-75. PubMed ID: 15752922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Observational study and participant-level meta-analysis on antihypertensive drug treatment-related cardiovascular risk.
    Asayama K
    Hypertens Res; 2017 Oct; 40(10):856-860. PubMed ID: 28446803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ambulatory Blood Pressure Monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults.
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F
    Chronobiol Int; 2015; 32(10):1329-42. PubMed ID: 26587588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
    Mancia G; Kjeldsen SE; Zappe DH; Holzhauer B; Hua TA; Zanchetti A; Julius S; Weber MA
    Eur Heart J; 2016 Mar; 37(12):955-64. PubMed ID: 26590384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in the treatment of hypertension.
    Hering D; Esler MD; Krum H; Mahfoud F; Böhm M; Sobotka PA; Schlaich MP
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):729-44. PubMed ID: 21714604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.